Rhizome, acts as an inhibitor of HDAC, with an IC50 of 2.27 mM, and also inhibits ACE-I activity. Sinapinic acid posssess potent anti-tumor activity, induces apoptosis of tumor cells. Sinapinic acid shows antioxidant and antidiabetic activities. Sinapinic acid reduces total cholesterol, triglyceride, and HOMA-IR index, and also normalizes some serum parameters of antioxidative abilities and oxidative damage in ovariectomized rats.
Caractéristiques techniques
| Marque | MedChemExpress |
| Réf. B-LABO | BL-RE-170619 |
| Réf. fabricant | 16499336 |
| Contenu et stockage | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
|---|
| Poids moléculaire | 224.21 g/mol |
|---|
| Conditions d’expédition | Room temperature |
|---|
| À utiliser avec (application) | Cancer-programmed cell death |
|---|
| CAS | 530-59-6 |
|---|
| Type de produit | Natural Products |
|---|
| Pureté | 98.9% |
|---|
| Solubilité | DMSO : 100 mg/mL (446.01 mM∣Need ultrasonic) ∣Ethanol : 25 mg/mL (111.50 mM∣Need ultrasonic) |
|---|
| Synonyme | Sinapic acid |
|---|
| Cible | HDAC∣Angiotensin-converting Enzyme (ACE)∣Reactive Oxygen Species∣Apoptosis |
|---|
| Quantité | 100 mg |
Une question, une configuration particulière ?
Contactez-nous pour un devis.